Coagulation factors are protein components of the blood which serve blood coagulation.
Search results 51 to 75 from a total of 87
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|---|---|---|---|
|
Beriate 2000 |
CSL Behring GmbH |
10505a/98-4 | 11.12.2012 | Rote-Hand-Brief: Beriate (09.08.2019) |
|
Beriplex P/N 1000 |
CSL Behring GmbH |
10501a/95a | 26.01.2013 | |
|
Voncento |
CSL Behring GmbH |
EU/1/13/857 | 12.08.2013 | |
|
NovoEight |
Novo Nordisk A/S, Denmark |
EU/1/13/888 | 13.11.2013 | |
|
Cluvot 250 I.E. |
CSL Behring GmbH |
PEI.H.11666.01.1 | 07.03.2014 | |
|
Cluvot 1250 I.E. |
CSL Behring GmbH |
PEI.H.11666.02.1 | 07.03.2014 | |
|
Nuwiq |
Octapharma AB, Stockholm |
EU/1/14/936 | 22.07.2014 | |
Prothromplex NF 600 |
Takeda GmbH |
PEI.H.11717.01.1 | 13.08.2014 | |
|
Rixubis |
Baxter Innovations GmbH |
EU/1/14/970 | 19.12.2014 | |
WILLFACT 2000 I.E. |
LFB-Biomedicaments |
PEI.H.03530.03.1 | 24.12.2014 | |
WILLFACT 500 I.E. |
LFB-Biomedicaments |
PEI.H.03530.02.1 | 24.12.2014 | |
|
Octaplex 1000 |
OCTAPHARMA GmbH |
PEI.H.02312.02.1 | 11.08.2015 | |
|
Obizur |
Baxalta Innovations GmbH, A |
EU/1/15/1035 | 11.11.2015 | |
|
Elocta |
Swedish Orphan Biovitrum AB (publ) |
EU/1/15/1046 | 19.11.2015 | |
|
FibCLOT |
Laboratoire Français du Fractionnement et des Biotechnologies, F Les Ulis |
PEI.H.11771.01.1 | 05.02.2016 | |
|
Kovaltry |
Bayer AG |
EU/1/15/1076 | 18.02.2016 | |
|
Coagadex |
Bio Products Laboratory Ltd., UK-Hertfordshire |
EU/1/16/1087 | 16.03.2016 | |
|
Idelvion |
CSL Behring GmbH |
EU/1/16/1095 | 11.05.2016 | |
|
Alprolix |
Swedish Orphan Biovitrum AB (publ) |
EU/1/16/1098 | 12.05.2016 | |
|
Afstyla |
CSL Behring GmbH |
EU/1/16/1158 | 04.01.2017 | |
|
Vihuma |
Octapharma AB, Stockholm |
EU/1/16/1168 | 13.02.2017 | |
|
Refixia |
Novo Nordisk A/S, Denmark |
EU/1/17/1193 | 02.06.2017 | |
|
Fibryga |
Octapharma GmbH |
PEI.H.11879.01.1 | 23.06.2017 | |
|
Adynovi |
Baxalta Innovations GmbH, A |
EU/1/17/1247 | 08.01.2018 | |
|
Veyvondi |
Baxalta Innovations GmbH |
EU/1/18/1298 | 31.08.2018 |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 529 in BAnz AT 30.05.2025 B6.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 02.06.2025
